| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| FON_NAZ - Bandi Altre Fondazioni |
Targeting lipids in CLN8-associated NCL diseases: structural and functional interaction of CLN8 with vesicle-associated membrane protein-associated protein A (VAPA), and genotype-phenotype correlations
|
|
Closed | 2016 |
| FON_NAZ - Bandi Altre Fondazioni |
Meninges as an overlooked pharmacological target for Globoid Cell Leukodystrophy
|
|
Closed | 2020 |
| FON_NAZ - Bandi Altre Fondazioni |
Comorbidità tra slerosi multipla e depressione: ruolo degli eventi avversi in età precoce
|
|
Closed | 2016 |
| FON_NAZ - Bandi Altre Fondazioni |
NK-DC crosstalk in glioma microenvironment explored by single-cell RNAseq (1º anno)
|
|
Closed | 2021 |
| FON_NAZ - Bandi Altre Fondazioni |
Functional relevance of different tetraspanin-like MS4A members for FcRs antitumor activities in target therapies (1º anno)
|
|
Closed | 2021 |
| FON_NAZ - Bandi Altre Fondazioni |
Exploiting innate lymphoid cells to predict clinical progression and response to therapy in myelodysplastic syndromes (1° anno)
|
|
Closed | 2022 |
| FON_NAZ - Bandi Altre Fondazioni |
Identification of molecular immune-metabolic profiles in pancreatic cancer to advance management of pancreatic diseases (2° anno)
|
|
Closed | 2022 |
| FON_NAZ - Bandi Altre Fondazioni |
The interplay between HPCAL4 and MeCP2: identification and characterization of a novel putative target for Rett syndrome therapy
|
|
Ongoing | 2022 |
| FON_NAZ - Bandi Altre Fondazioni |
Targeting allo-reactive Natural Killer cell immune reconstitution in hematologic tumors after bone marrow transplant (4° anno)
|
|
Closed | 2022 |
| FON_NAZ - Bandi Altre Fondazioni |
Functional relevance of different tetraspanin-like MS4A members for FcRs antitumor activities in target therapies (2° anno)
|
|
Closed | 2022 |
| FON_NAZ - Bandi Altre Fondazioni |
Evidence-based approach to treat hyperexcitability in Rett syndrome though splicing modulation
|
|
Ongoing | 2021 |
| FON_NAZ - Bandi Altre Fondazioni |
The natural antisense lncRNA PHOX2B-AS1 in the pathogenesis and as potential drug target in Congenital Central Hypoventilation Syndrome (CCHS)
|
|
Ongoing | 2023 |
| FON_NAZ - Bandi Altre Fondazioni |
Identification of molecular immune-metabolic profiles in pancreatic cancer to advance management of pancreatic diseases (3° anno)
|
|
Ongoing | 2023 |
| FON_NAZ - Bandi Altre Fondazioni |
All-optical fingerprinting of metastatic potential (5° anno)
|
|
Ongoing | 2023 |
| FON_NAZ - Bandi Altre Fondazioni |
E-cigarettes: a realistic innovative mouse model for studying the addictive effects of nicotine exposure via electronic devices
|
|
Closed | 2014 |
| FON_NAZ - Bandi Altre Fondazioni |
New strategies to target Hyper-excitability in Rett Syndrome
|
|
Closed | 2014 |
| FON_NAZ - Bandi Altre Fondazioni |
mApoE-Functionalized Lipidic-and Polymeric-Nanocomposite for Human Glioblasonata Imaging and Treatment
|
|
Closed | 2014 |
| FON_NAZ - Bandi Altre Fondazioni |
Dissecting the genetic basis and molecular mechanisms of Premature Ovarian Failure
|
|
Closed | 2009 |
| FON_NAZ - Bandi Altre Fondazioni |
New approaches to the molecular pathogenesis of CCHS: implacations for therapeutics strategies
|
|
Closed | 2013 |
| FON_NAZ - Bandi Altre Fondazioni |
Definition of CDK5 in the tumor microenvironment
|
|
Closed | 2018 |
| FON_NAZ - Bandi Altre Fondazioni |
Excitatory/inhibitory unbalance in Ataxia Telangectasia and Perspective Therapeuthical Interventions
|
|
Closed | 2016 |
| FON_NAZ - Bandi Altre Fondazioni |
Metastasis AS Mechanodisease - 4° anno
|
|
Closed | 2022 |
| FON_NAZ - Bandi Altre Fondazioni |
Functional study on a new pharmacological approach in the Rett Syndrome
|
|
Ongoing | 2023 |
| FON_NAZ - Bandi Altre Fondazioni |
Metastasis AS Mechanodisease - 5° anno
|
|
Ongoing | 2023 |
| FON_NAZ - Bandi Altre Fondazioni |
Exploring the role of IL-6 in Rett syndrome: focus on astrocyte-neuron communication
|
|
Ongoing | 2023 |
| H20_RIA - Horizon 2020_Research & Innovation Action/Innovation Action |
Revolutionizing Healthcare by Tracking and Understanding Human Cells during Disease (LifeTime)
|
|
Closed | 2019 |
| H20_RIA - Horizon 2020_Research & Innovation Action/Innovation Action |
Enhanced Delivery Ecosystem for Neurosurgery in 2020
|
|
Closed | 2015 |
| Horizon Europe Global Challenge-RIA/IA/CSA |
The pandemic within: tackling brain vulnerability in COVID19 at high resolution: NEUROCOV
|
|
Ongoing | 2022 |
| INTLI - Finanziamenti internazionali |
Newly identified PHOX2B-regulated ion channels as possible drug targets for the pharmacological intervention in Congenital Central Hypoventilation Syndrome (CCHS)
|
|
Closed | 2017 |
| INTLI - Finanziamenti internazionali |
Study of the Biological Role of LSD1/KDM1A Splicing Variants in Human Embryonic Stem Cells and Early Development
|
|
Closed | 2020 |
| INTLI - Finanziamenti internazionali |
Role of glycan chain of ganglioside GM1 in modulating the neuronal signaling
|
|
Closed | 2020 |
| INTLI - Finanziamenti internazionali |
Neural stem precursor cell therapy: a novel therapeutic approach for the treatment of Rett syndrome
|
|
Closed | 2020 |
| INTLI - Finanziamenti internazionali |
Deciphering the principles of cell decision-making in multicellular system. The Least microEnvironmental Unertainty Pinciples (LEUP)
|
|
Ongoing | 2020 |
| INTLI - Finanziamenti internazionali |
Cellular and molecular drug screening system for Rett syndrome therapy
|
|
Closed | 2020 |
| INTLI - Finanziamenti internazionali |
Branched chain amino acids-induced persistent metabolic shift towards oxidative phosphorylation in immune and neural cells: a potential new therapy for Progressive Multiple Sclerosis
|
|
Closed | 2021 |
| INTLI - Finanziamenti internazionali |
Ampakine-mediated modulation of neuronal activity for the treatment of Rett syndrome: proposal for a preclinical study
|
|
Closed | 2021 |
| INTLI - Finanziamenti internazionali |
GM1-oligosaccharide as a new drug candidate for Rett syndrome
|
|
Closed | 2021 |
| INTLI - Finanziamenti internazionali |
Dissecting the molecular mechanism linking GCase-dependent lysosomal impairment with Parkinson’s disease
|
|
Closed | 2022 |
| INTLI - Finanziamenti internazionali |
The lncRNA PHOX2B-AS1 in the pathogenesis and as potential drug target in Congenital Central Hypoventilation Syndrome (CCHS)
|
|
Ongoing | 2023 |
| INTLI - Finanziamenti internazionali |
Targeting Drp1 activation and mitochondrial Fission tO Curtail muscle wasting during Duchenne MUscular DyStrophy progression (FOCUS)
|
|
Ongoing | 2022 |
